Spots Global Cancer Trial Database for investigator's choice chemotherapy
Every month we try and update this database with for investigator's choice chemotherapy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in R/R DLBCL | NCT04628494 | Diffuse Large B... | Epcoritamab Investigator's ... | 18 Years - | Genmab | |
Safety and Efficacy of Blinatumomab in Adults With Newly Diagnosed High-risk Diffuse Large B-Cell Lymphoma | NCT03023878 | High-risk Diffu... | Blinatumomab Investigator's ... Dexamethasone | 18 Years - 100 Years | Amgen | |
A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer | NCT05652894 | Metastatic Colo... | HX008 Investigator's ... | 18 Years - | Taizhou Hanzhong biomedical co. LTD |